Doucet-O'Hare Tara T, Rosenblum Jared S, Shah Ashish H, Gilbert Mark R, Zhuang Zhengping
National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA.
National Institutes of Neurological Disorders and Stroke (NINDS), Surgical Neurology Branch, Bethesda, MD 20892, USA.
J Pers Med. 2021 Dec 8;11(12):1332. doi: 10.3390/jpm11121332.
Human endogenous retroviruses (HERVs), which are critical to normal embryologic development and downregulated during normal maturation, have been implicated in a variety of cancers. Abnormal persistent production of HERVs has been suggested to play a role in oncogenesis and to confer stem cell properties to cells. We recently demonstrated that the most recently incorporated HERV element (HERV-K HML-2) has been associated with the pathogenesis of the embryonal atypical teratoid rhabdoid tumor (AT/RT), shifting our understanding of embryonal tumor development. HML-2 expression is vital for proper human development and its expression is suppressed via methylation or chromatin remodeling as cells differentiate. We previously found that dysfunctional chromatin remodeling due to loss of SMARCB1 expression induces HML-2 envelope (env) expression, impairing cellular differentiation and migration, and facilitating tumor growth in AT/RT. Epigenetic dysregulation in other embryonal tumors with concomitant expression of stem-cell markers may facilitate HML-2 expression. Future studies could utilize HML-2 as potential diagnostic criteria, use its expression as a treatment biomarker, and investigate the efficacy of therapies targeting cells with high HML-2 expression.
人类内源性逆转录病毒(HERVs)对正常胚胎发育至关重要,且在正常成熟过程中表达下调,目前已发现其与多种癌症有关。有研究表明,HERVs的异常持续产生在肿瘤发生中起作用,并赋予细胞干细胞特性。我们最近证明,最新整合的HERV元件(HERV-K HML-2)与胚胎型非典型畸胎样横纹肌样瘤(AT/RT)的发病机制有关,这改变了我们对胚胎肿瘤发展的理解。HML-2的表达对人类正常发育至关重要,随着细胞分化,其表达通过甲基化或染色质重塑被抑制。我们之前发现,由于SMARCB1表达缺失导致的染色质重塑功能障碍会诱导HML-2包膜(env)表达,损害细胞分化和迁移,并促进AT/RT中的肿瘤生长。其他伴有干细胞标志物表达的胚胎肿瘤中的表观遗传失调可能会促进HML-2表达。未来的研究可以将HML-2用作潜在的诊断标准,将其表达用作治疗生物标志物,并研究针对高HML-2表达细胞的治疗效果。